Helius Medical Approves 1-for-50 Reverse Stock Split Effective July 1, 2025
Helius Medical Technologies Inc. has approved a 1-for-50 reverse stock split of its Class A common stock, effective July 1, 2025. This decision, made by the Board of Directors, aims to meet Nasdaq’s listing requirements. The stock will continue to trade under the symbol "HSDT" with a new CUSIP number.
Helius Medical Technologies Inc. announced an amendment to its Certificate of Incorporation to implement a 1-for-50 reverse stock split of its Class A common stock. This move, approved by the Board of Directors and effective July 1, 2025, is intended to comply with Nasdaq’s listing requirements. The company’s stock will continue to trade under the symbol “HSDT” with a new CUSIP number. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Helius Medical Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-008942), on June 27, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
